Earnings Summary: Moderna reports Q2 2024 financial results

[ad_1] Biotechnology company Moderna, Inc. (NASDAQ: MRNA) Thursday reported a sharp decline in revenues for the second quarter of 2024. Second-quarter revenues decreased to $241 million from $344 million in the prior-year period Net loss narrowed to $1.28 billion or…







